Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 376-378, February 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heidrick, M. L.
Right arrow Articles by Ryan, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heidrick, M. L.
Right arrow Articles by Ryan, W. L.

Cyclic Nucleotides on Cell Growth in Vitro1

Margaret L. Heidrick2 and Wayne L. Ryan

Eppley Institute for Cancer Research, University of Nebraska College of Medicine, Omaha, Nebraska 68105

The growth of four tumorigenic cell lines was inhibited from 70 to 89% by adenosine 3', 5'-cyclic monophosphate (0.3 mM) whereas a nonmalignant cell line (WI-38) was affected only slightly (13%). Adenosine 2',3'-cyclic monophosphate (0.3 mM) was less active, inhibiting the tumorigenic cell lines from 23 to 56%.

The other cyclic purine nucleotides investigated (guanosine 3',5'-cyclic monophosphate and quanosine 2',3'-cyclic monophosphate) did not show selectivity; they inhibited the tumorigenic strains and the WI-38 cell line.

The 3',5'-cyclic pyrimidine nucleotides, with the exception of thymidine 3',5'-cyclic monophosphate, did not significantly inhibit any of the cell lines. Thymidine 3',5'-cyclic monophosphate produced inhibition of only strain L.

1 This research was supported by a Research Grant P-384C from the American Cancer Society.

2 Predoctoral trainee, USPHS Traineeship 2-TO1-HD-18.

Received 5/ 7/69. Accepted 7/16/69.




This article has been cited by other articles:


Home page
ScienceHome page
Y. S. Cho-Chung and P. M. Gullino
In vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMP
Science, January 11, 1974; 183(4120): 87 - 88.
[Abstract] [PDF]


Home page
ScienceHome page
W. L. Ryan and M. A. Durick
Adenosine 3',5'-Monophosphate and N6-2'-O-Dibutyryl-Adenosine 3',5'-Monophosphate Transport in Cells
Science, September 15, 1972; 177(4053): 1002 - 1003.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.